SCHEMBL21167443

SCHEMBL21167443

NNc1ncc(-c2cnn(CCO)c2)nc1NCc1ccn2nccc2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 12/20 0.42
JAK2 O60674 2/20 0.39
JAK1 P23458 2/20 0.39
TYK2 P29597 2/20 0.39
JAK3 P52333 2/20 0.39
PDE3B Q13370 2/20 0.36
PDE3A Q14432 2/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
CSF1R P07333 1/20 0.36
CYP2C9 P11712 1/20 0.35
PDE10A Q9Y233 1/20 0.35
FGFR1 P11362 2/20 0.35
FGFR3 P22607 2/20 0.35
KDR P35968 2/20 0.35
FGFR2 P21802 1/20 0.35
FGFR4 P22455 1/20 0.35
SYK P43405 1/20 0.35
FLT3 P36888 1/20 0.34
FEN1 P39748 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24591017 0.91 MET (0.43) METJAK2JAK1TYK2JAK3
SCHEMBL21167444 0.90 CSF1R (0.46) METJAK2JAK1TYK2JAK3
SCHEMBL22475667 0.78 MET (0.57) METPDE3BPDE3APDE4CPDE4D
SCHEMBL22475669 0.77 MET (0.41) METPDE3BPDE3ACSF1RCYP2C9
SCHEMBL24590999 0.76 MET (0.44) METCSF1RPDE10A
SCHEMBL21167604 0.76 CSF1R (0.62) METCSF1RFGFR1FGFR3FGFR2
SCHEMBL22475809 0.75 MET (0.60) METJAK2JAK3PDE3BPDE3A
SCHEMBL21167599 0.74 MET (0.60) METJAK2JAK1TYK2JAK3
SCHEMBL21167564 0.73 MET (0.59) METPDE3BPDE3APDE4CPDE4D
SCHEMBL24591095 0.73 MET (0.40) METPDE3BPDE3APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3511330-A1 SYNTHETIC INTERMEDIATE USEFUL IN THE PREPARATION OF TRIAZOLOPYRIDINE C-MET INHIBITORS Hutchison Medipharma Limited (CN) 2019-07-17 EP disclosed